Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Estradiol valerate + cyproterone acetate is a combination hormone therapy medication that pairs an estrogen (estradiol valerate) with an antiandrogen and progestin (cyproterone acetate). This combination is primarily used for hormone replacement therapy in menopausal women and treatment of androgen-dependent conditions. Estradiol valerate is a prodrug of estradiol that improves oral bioavailability, while cyproterone acetate blocks androgen receptors and has progestogenic effects. The medication is typically administered in a sequential regimen.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on estradiol valerate + cyproterone acetate.